| 发明名称 |
Glaucoma treatment |
| 摘要 |
Elevated glutamate levels are associated with glaucoma, and damage to retinal ganglion cells can be controlled by administering to the patient a compound capable of reducing glutamate induced excitotoxicity in a concentration effective to cause reduction of such excitotoxicity.
|
| 申请公布号 |
US5922773(A) |
申请公布日期 |
1999.07.13 |
| 申请号 |
US19920984939 |
申请日期 |
1992.12.04 |
| 申请人 |
THE CHILDREN'S MEDICAL CENTER CORP.;MASSACHUSETTS EYE AND EAR INFIRMARY |
发明人 |
LIPTON, STUART A.;DREYER, EVAN B. |
| 分类号 |
A61K38/16;A61K31/00;A61K31/13;A61K31/195;A61K31/21;A61K35/56;A61K35/58;A61K38/46;A61K45/00;A61K45/08;A61P3/00;A61P27/02;A61P27/06;A61P43/00;(IPC1-7):A61K31/135 |
主分类号 |
A61K38/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
